Smith+Nephew, OrthoPediatrics, Stryker withdraw 2020 financial guidance due to COVID-19 & more: 9 device company notes

Eric Oliver -   Print  |

Here are nine key notes on spine and orthopedic device companies:

Smith+Nephew withdrew its full-year 2020 guidance due to the COVID-19 pandemic.

OrthoPediatrics on March 30 withdrew its 2020 revenue projections that estimated growth within the range of 22 percent to 24 percent.

Styker is the latest company to withdraw its first-quarter and full-year 2020 financial projections due to the COVID-19 pandemic.

Medtronic is introducing two online platforms for at-home COVID-19 symptom monitoring and support.

Consulting firm OrthoSpine Partners is collaborating with Swift Response to provide first responders with the protection they need while on the front lines of the COVID-19 pandemic.

Nexxt Spine on March 31 launched its Matrixx corpectomy system for spine surgery.

The FDA granted OrthoPediatrics 510(k) clearance to expand its Response Scoliosis system to include neuromuscular implants on March 31.

Medtronic and DePuy Synthes representatives told Times Union Online about measures they've implemented to protect local employees and support healthcare providers during the COVID-19 pandemic.

The FDA awarded AgNovos Healthcare's AGN1 Local Osteo-enhancement Procedure small volume kit breakthrough device designation on March 26.

More articles on surgery centers:
ASCs could get financial relief under $2 trillion stimulus law — 4 things to know
Can ASCs help with the COVID-19 surge?
California's 750+ ASCs prepare to expand services for COVID-19 surge

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers